Biography:James D. Griffin (scientist)
James D. Griffin | |
|---|---|
| Born | James Douglas Griffin Syracuse, New York |
| Alma mater |
|
| Scientific career | |
| Institutions |
|
James D. Griffin is an American physician-scientist. He is currently Professor of Medicine at Harvard Medical School, Chair of Medical Oncology at Dana–Farber Cancer Institute, and Director of Medical Oncology at Brigham and Women's Hospital.[1][2] He is considered an expert in medical oncology and is widely recognized for his research in the clinical and biologic aspects of hemotologic malignancies.
Griffin completed a Bachelor of Arts at Brown University in 1970. He attended Harvard Medical School, earning his M.D. in 1974. Griffin completed his residency at Johns Hopkins Hospital, a hematology fellowship at Massachusetts General Hospital, and a medical oncology fellowship at Dana–Farber Cancer Institute.[3]
He is on the scientific advisory boards of Phio Pharmaceuticals, the Georgetown Lombardi Comprehensive Cancer Center, and the Johns Hopkins Cancer Center.[4]
Griffin was born in Syracuse, New York. He is a seventh-generation Irish American.[5]
References
- ↑ "James D. Griffin, MD - Dana-Farber Cancer Institute | Boston, MA". https://www.dana-farber.org/find-a-doctor/james-d-griffin/.
- ↑ "James D. Griffin, MD - DF/HCC". https://www.dfhcc.harvard.edu/insider/member-detail/member/james-d-griffin-md/.
- ↑ Corporation, RXi Pharmaceuticals. "RXi Pharmaceuticals Appoints Medical Oncology Expert, Dr. James Griffin, to Scientific Advisory Board" (in en). https://www.prnewswire.com/news-releases/rxi-pharmaceuticals-appoints-medical-oncology-expert-dr-james-griffin-to-scientific-advisory-board-300406480.html.
- ↑ walid (2021-06-28). "Phio Pharmaceuticals | About Us" (in en-US). https://phiopharma.com/about/.
- ↑ "James Griffin" (in en-US). https://www.irishamerica.com/honoree/james-griffin/.
External links
- James D. Griffin publications indexed by Google Scholar
 |
